Form 4: Cardio Diagnostics Holdings Director Acquires and Disposes of Stock Options
SEC Form 4
Paul Frederick Burton, a director of Cardio Diagnostics Holdings, Inc., reports acquiring and disposing of stock options on September 30, 2024.
Summary
- On September 30, 2024, Paul Frederick Burton, a director of Cardio Diagnostics Holdings, Inc., engaged in transactions involving derivative securities.
- Specifically, Mr. Burton acquired 18,686 stock options with an exercise price of $0.22.
- These options are exercisable immediately and expire on September 30, 2034.
- Mr. Burton also disposed of 26,261 stock options at a price of $0.22.
- Following these transactions, Mr. Burton beneficially owns 26,261 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report of stock option transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly diluting the stock if the options are exercised in the future.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of earliest transaction: Acquisition and disposal of stock options. |
| 09/30/2024 | Date stock options are exercisable. |
| 09/30/2034 | Expiration date of stock options. |
| 10/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.